Instituto Universitario de Bio-Orgánica Antonio González (IUBO AG), Departamento de Química Orgánica, Universidad de La Laguna (ULL), Avda. Astrofísico F. Sánchez, 2, 38206 La Laguna, Tenerife, Spain.
Facultad de Ciencias Biológicas (FCB), Universidad Autónoma de Nuevo León (UANL), Av. Pedro de Alba s/n, 66450 San Nicolás de los Garza, Nuevo León, Mexico.
Mar Drugs. 2020 May 30;18(6):287. doi: 10.3390/md18060287.
Marine environments represent a great opportunity for the discovery of compounds with a wide spectrum of bioactive properties. Due to their large variety and functions derived from natural selection, marine natural products may allow the identification of novel drugs based not only on newly discovered bioactive metabolites but also on already known compounds not yet thoroughly investigated. Since drug resistance has caused an increase in infections by and nontuberculous mycobacteria, the re-evaluation of known bioactive metabolites has been suggested as a good approach to addressing this problem. In this sense, this study presents an evaluation of the in vitro effect of laurinterol and aplysin, two brominated sesquiterpenes isolated from , against nine strains and six nontuberculous mycobacteria (NTM). Laurinterol exhibited good antimycobacterial activity, especially against nontuberculous mycobacteria, being remarkable its effect against , with minimum inhibitory concentration (MIC) values lower than those of the reference drug imipenem. This study provides further evidence for the antimycobacterial activity of some sesquiterpenes from , which can be considered interesting lead compounds for the discovery of novel molecules to treat NTM infections.
海洋环境为发现具有广泛生物活性的化合物提供了绝佳的机会。由于它们的多样性和自然选择衍生的功能,海洋天然产物可能不仅允许基于新发现的生物活性代谢物,而且还允许基于尚未深入研究的已知名化合物来识别新的药物。由于抗药性导致 和非结核分枝杆菌的感染增加,已经提出重新评估已知的生物活性代谢物是解决这个问题的一个很好的方法。在这种意义上,本研究评估了从 中分离出的两种溴代倍半萜类化合物 laurinterol 和 aplysin 对 9 株 和 6 株非结核分枝杆菌(NTM)的体外作用。Laurinterol 表现出良好的抗分枝杆菌活性,特别是对非结核分枝杆菌,其对 的作用尤为显著,最低抑菌浓度(MIC)值低于参考药物亚胺培南。本研究为 中的一些倍半萜类化合物的抗分枝杆菌活性提供了进一步的证据,这些化合物可以被认为是发现治疗非结核分枝杆菌感染的新型分子的有趣先导化合物。